unbuzzd

Biotech

Quantum BioPharma Expands Reach With New unbuzzd Launch and Cutting-Edge MS Clinical Study

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is making headlines in April, launching its innovative alcohol detox drink, unbuzzd™,…

Read More »
Biotech

Quantum BioPharma Boasts Enhanced Financials, Clinical Successes, and New Alcohol Misuse Treatment

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is riding a wave of optimism following robust financial improvements, promising clinical…

Read More »
Technical Analysis

Why This Low Float Biotech Stock Looks Ripe for Another Big Breakout

Shares of Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), an up-and-coming biotech stock with a tiny float,…

Read More »
Biotech

Quantum BioPharma Licensee Celly Nutrition Eyes IPO Following Highly Successful unbuzzd Clinical Trial

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced that its licensee, Celly Nutrition, the company behind unbuzzd™, the…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content